Psychedelics: Where we are now, why we got here, what we must do
Belouin, S. J., & Henningfield, J. E. | Neuropharmacology | 21 February 2018
Powerful substances in tiny amounts An interview study of psychedelic microdosing
Johnstad, P. G. | Nordic Studies on Alcohol and Drugs | 15 February 2018
The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson’s disease
Fisher, R., Lincoln, L., Jackson, M. J., Abbate, V., Jenner, P., Hider, R., ... & Rose, S. | Phytotherapy Research | 24 January 2018
Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter
Kuypers, K. P. C., de la Torre, R., Farre, M., Xicota, L., Perna, E. D. S. F., Theunissen, E. L., & Ramaekers, J. G. | Scientific reports | 18 January 2018
Novel psychotherapeutics – a cautiously optimistic focus on Hallucinogens
Sherwood, A. M., & Prisinzano, T. E. | Expert Review of Clinical Pharmacology | 17 December 2017
Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD
Atasoy, S., Roseman, L., Kaelen, M., Kringelbach, M. L., Deco, G., & Carhart-Harris, R. L. | Scientific reports | 15 December 2017
Acute effects of methylphenidate, modafinil and MDMA on negative emotion processing
Schmidt, A., Müller, F., Dolder, P. C., Schmid, Y., Zanchi, D., Egloff, L., ... & Borgwardt, S. | International Journal of Neuropsychopharmacology | 1 December 2017
Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action
Maltbie, E. A., Kaundinya, G. S., & Howell, L. L. | Behavioural Pharmacology | 1 December 2017
Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways
Xu, B., Li, M., Yu, Y., He, J., Hu, S., Pan, M., ... & Zhu, J. | Oncology Letters | 28 November 2017
A regulatory perspective on the evaluation of hallucinogen drugs for human use
Calderon, S. N., Hunt, J., & Klein, M. | Neuropharmacology | 24 November 2017
Regulation of human research with LSD in the United States (1949-1987)
Bonson, K. R. | Psychopharmacology | 17 November 2017
Multipotent and Poly-therapeutic Fungal Alkaloids of Claviceps purpurea
Majrashi, M., Ramesh, S., Deruiter, J., Mulabagal, V., Pondugula, S., Clark, R., & Dhanasekaran, M. | Medicinal Plants and Fungi: Recent Advances in Research and Development | 4 November 2017
LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm
Timmermann, C., Spriggs, M. J., Kaelen, M., Leech, R., Nutt, D. J., Moran, R. J., ... & Muthukumaraswamy, S. D. | Neuropharmacology | 31 October 2017
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Dakic, V., Nascimento, J. M., Sartore, R. C., de Moraes Maciel, R., Araujo, D. B., Ribeiro, S., ... & Rehen, S. K. | Scientific Reports | 9 October 2017
Salvinorin A reduces neuropathic nociception in the insular cortex of the rat
Coffeen, U., Canseco‐Alba, A., Simón‐Arceo, K., Almanza, A., Mercado, F., León‐Olea, M., & Pellicer, F. | European Journal of Pain | 4 October 2017
Acute LSD effects on response inhibition neural networks
Schmidt, A., Müller, F., Lenz, C., Dolder, P. C., Schmid, Y., Zanchi, D., ... & Borgwardt, S. | Psychological Medicine | 2 October 2017
The relationships of classic psychedelic use with criminal behavior in the United States adult population
Hendricks, P. S., Crawford, M. S., Cropsey, K. L., Copes, H., Sweat, N. W., Walsh, Z., & Pavela, G. | Journal of Psychopharmacology | 1 October 2017
Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music
Barrett, F. S., Preller, K. H., Herdener, M., Janata, P., & Vollenweider, F. X. | Cerebral Cortex | 28 September 2017
Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations
Mueller, F., Lenz, C., Dolder, P., Lang, U., Schmidt, A., Liechti, M., & Borgwardt, S. | Acta Psychiatrica Scandinavica | 21 September 2017
Identification of ω-N-Methyl-4-hydroxytryptamine (Norpsilocin) as a Psilocybe Natural Product
Lenz, C., Wick, J., & Hoffmeister, D. | Journal of Natural Products | 20 September 2017
Harmine suppresses the proliferation and migration of human ovarian cancer cells through inhibiting ERK/CREB pathway
Gao, J., Zhu, H., Wan, H., Zou, X., Ma, X., & Gao, G. | Oncology Reports | 13 September 2017
Psychedelic pleasures: An affective understanding of the joys of tripping
Bøhling, F. | International Journal of Drug Policy | 13 September 2017
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R. L., & Nutt, D. J. | Journal of Psychopharmacology | 31 August 2017
MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s)
Passie, T., & Benzenhöfer, U. | Drug testing and analysis | 29 August 2017
Enzymatic synthesis of psilocybin
Fricke, J., Blei, F., & Hoffmeister, D. | Angewandte Chemie International Edition | 25 August 2017